Intel unveiled several significant innovations in AI at Computex 2026, aimed at addressing customer needs for chip-to-systems-level solutions. The announcements included a new rackscale AI infrastructure designed for use with Intel Xeon processors and SambaNova SN-50 Reconfigurable Dataflow Units (RDUs), enabling clients to scale their inference and agentic workloads.
A new enterprise inference cloud called Vector Core Compute was introduced, developed in partnership with Vista Equity Partners and Cambium Capital. This system features fully disaggregated inference, leveraging Intel Xeon processors, SambaNova RDUs, and NVIDIA Blackwell GPUs for efficient processing.
Intel also showcased strategic collaborations with companies such as Foxconn, Siemens, Hitachi, Echo Neurotechnologies, and Greenstone Biosciences. These partnerships are focused on delivering integrated vertical solutions that utilize Intel processors and custom silicon tailored to specific industry applications.
The next-generation Intel Xeon 6+ processors, built on the Intel 18A architecture, were announced as designed for high-density, scalable workloads in data centers. With a focus on power efficiency, a single liquid-cooled rack can host 36,864 cores with a 100-kilowatt power compute capacity.
The Series 3 family of processors has also seen considerable support from partners and customers, now being used in more than 325 designs for consumer and commercial PCs. Intel confirmed that Series 3 processors are now expanding into handheld gaming with the release of its Intel Arc G-series processors.
Foxconn will provide these systems for rackscale AI infrastructure, specializing in manufacturing CPU-dense variants optimized for varied workloads. They will also explore potential collaborations with Intel in custom silicon design and development services.
Siemens, which began its collaboration with Intel in 2023, is looking to enhance its initiatives across various compute requirements, which may include edge devices and robotics. Hitachi has also announced plans to work with Intel on a range of solutions that incorporate foundry tools and quantum computing technologies.
Echo Neurotechnologies and Intel are investigating neuromorphic technologies aimed at advancing neuro-AI and related fields, while Greenstone Biosciences intends to leverage Intel’s tools to enhance drug development capabilities.
Intel stated its focus on designing products that will improve customer experiences and contribute positively to various industries, with Lip-Bu Tan, CEO of Intel, noting the company’s commitment to innovation in AI. The Xeon 6+ processors are expected to support the future demands of cloud-native, network-intensive workloads.
The collaborations and technological advancements outlined at the event underscore Intel’s broadened strategy in the increasingly important AI market, where effective infrastructure and tailored solutions are key to meeting diverse customer needs.
